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Abstract
 
Ionic signaling pathways, including voltage-dependent potassium (Kv) channels, are instru-
mental in antigen-mediated responses of peripheral T cells. However, how Kv channels coop-
erate with other signaling pathways involved in T cell activation and differentiation is un-
known. We report that multiple Kv channels are expressed by naive CD4
 
 
 
 lymphocytes, and
that the current amplitude and kinetics are modulated by antigen receptor–mediated stimula-
tion and costimulatory signals. Currents expressed in naive CD4
 
 
 
 lymphocytes are consistent
with Kv1.1, Kv1.2, Kv1.3, and Kv1.6. Effector CD4
 
 
 
 cells generated by optimal TCR and co-
stimulation exhibit only Kv1.3 current, but at approximately sixfold higher levels than naive
cells. CD4
 
 
 
 lymphocytes anergized through partial stimulation exhibit similar Kv1.1, Kv1.2,
and/or Kv1.6 currents, but approximately threefold more Kv1.3 current than naive cells. To
determine if Kv channels contribute to the distinct functions of naive, effector, and anergized T
cells, we tested their role in immunoregulatory cytokine production. Each Kv channel is re-
quired for maximal IL-2 production by naive CD4
 
 
 
 lymphocytes, whereas none appears to
play a role in IL-2, IL-4, or IFN-
 
 
 
 production by effector cells. Interestingly, Kv channels in
anergized lymphocytes actively suppress IL-4 production, and these functions are consistent
with a role in regulating the membrane potential and calcium signaling.
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Introduction
 
Immune responses are initiated and regulated by the physi-
cal interactions of receptors and ligands on lymphocytes
and APCs, and by soluble signaling factors including cyto-
kines and chemokines, which are produced by APCs and
inflammatory cells. Therefore, dynamic external factors
shape the ongoing responsiveness of T cells, as do intrinsic
changes in their physiological state. One important intrinsic
determinant of T cell responsiveness is the membrane po-
tassium permeability, which is modulated by potassium
channels. Potassium channels play an essential role in imma-
ture thymocyte expansion (1) and effector activities of pe-
ripheral human lymphocytes (2). Charybdotoxin (CTX)
 
*
 
and margatoxin (MgTX), which block the predominant
voltage-dependent potassium (Kv) channel (Kv1.3) of pe-
ripheral lymphocytes, depolarize the plasma membrane (3–
5), and thereby inhibit TCR-mediated calcium influx (6–
8), IL-2 production (9), and proliferation (9, 10). Kv
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Kv Channels and CD4
 
 
 
 Lymphocyte Differentiation
 
channels also regulate the loss of intracellular K
 
 
 
, which is a
prerequisite step in normotonic or FAS-mediated apoptosis
(11–13) and regulatory volume responses to hypotonic
(low osmolarity) stress (6). In naive lymphocytes, Kv chan-
nels regulate the activation of 
 
 
 
-integrins (14), which par-
ticipate in cellular adhesion and transmigration through the
endothelium of venules.
Consequently, any regulation of Kv channel expression
or permeation during T cell differentiation could affect
their physiological state and functional responses. In fact,
the kinetics and amplitude of Kv currents are regulated
during murine thymocyte maturation (15–17) and after mi-
togen stimulation of human (18, 19) and murine peripheral
T lymphocytes in vitro (20). Moreover, in vivo adminis-
tered peptide inhibitors of Kv1.3 suppress delayed type hy-
persensitivity responses and antigen-specific antibody pro-
duction in miniswine (21) as well as immune-mediated
neurodegeneration in models of experimental allergic en-
cephalitis in the rat (22, 23). These studies collectively sug-
gest that Kv channels regulate physiological functions that
define key immunological responses of T cells.
Given the well established role for Kv channels in regu-
lating cell volume, apoptosis, membrane potential, and cal-
cium influx, and the critical role of calcium in T cell dif-
ferentiation, and IL-2 production in particular, we
hypothesized that Kv channels may contribute to the
unique physiology and responsiveness of naive and differen-
tiated T cells. To address this hypothesis, we defined the
modulation, by TCR and costimulation, of Kv currents in
naive, effector, and anergic CD4
 
 
 
 lymphocytes, and the
role of each current component in cytokine production.
We directly measured the amplitude, kinetic properties, and
pharmacology of Kv current in primary murine lympho-
cytes as well as the contribution of each current component
to the steady-state membrane potential. We report that
CD4
 
 
 
 T cells express multiple Kv1 (Shaker-related) family
potassium channel isoforms and that antigen stimulation in
vivo evokes distinct expression patterns in productively
primed (effector) and primed nonproliferating (anergic)
CD4
 
 
 
 cells. Moreover, Kv channels in naive, effector, and
anergic cells each contribute differently to the production of
key immunoregulatory cytokines including IL-2, IL-4, and
IFN-
 
 
 
. The mechanism of cytokine regulation by Kv chan-
nels corresponds to their role in regulating the membrane
potential and calcium signaling in each T cell population.
 
Materials and Methods
 
Stimulation of Transgenic CD4
 
 
 
 Lymphocytes In Vivo.
 
The
Mls-1
 
a
 
 reactive V
 
 
 
8.1 TCR transgenic mouse used in these
studies has been described previously (24). Greater than 98% of
peripheral T cells in this mouse express a V
 
 
 
8.1 TCR transgene.
Transgenic T cells were activated in vivo by intravenous inocu-
lation of T lymphocyte–depleted splenocytes (primarily B cells)
from CBA/J mice (Mls-1
 
a
 
 positive) that were prepared as de-
scribed previously (25). In brief, the spleen capsule was disrupted
with 22-gauge hypodermic needles allowing the release of lym-
phocytes. Red blood cells in unfractionated splenocyte prepara-
tions were lysed with Gey’s solution. The RBC-depleted prepa-
ration was incubated with anti-Thy1 mAb (3O-H12; BD
Biosciences) and Thy-1
 
 
 
 cells (T lymphocytes) were depleted by
complement (H-2 complement; Pel Freeze) lysis. Transgenic T
cells were stimulated by intravenous inoculation of V
 
 
 
8.1 TCR
transgenic mice with 15 million (in 0.15 ml PBS) T cell–depleted
CBA/J splenocytes.
 
CD4
 
 
 
 Lymphocyte Purification.
 
Inguinal, popliteal, axillary,
and submandibular lymph nodes were removed from mice and
placed into complete RPMI medium. The lymph node capsule
was disrupted with sterile 25-gauge hypodermic needles to release
lymphocytes and large debris was removed by filtration through
sterile nylon mesh (70 
 
 
 
M pore diameter). The filtered cell sus-
pension was first incubated with monoclonal antibodies (BD Bio-
sciences) against B220 (RA3–6B2), granulocytes (RB6–8C5),
Class I MHC (M5/114), and CD8 (Ly-2, 53–6.7). Antibody-
stained (non-CD4
 
 
 
) cells were removed by immunomagnetic de-
pletion (Miltenyi Biotec). Alternatively, washed antibody-treated
cells were complement killed. Dead cells were removed after
complement treatment by centrifugation over a Lympholyte
 
®
 
-M
(CEDARLANE Laboratories Ltd.) step gradient. Viable cells
were recovered and washed twice in RPMI medium before use
in proliferation experiments. The purity of nonstained (CD4
 
 
 
)
lymphocytes was determined by flow cytometry. These methods
yield a final population that contained at least 95% CD4
 
 
 
 cells.
 
Cell Culture and In Vitro Stimulation.
 
CD4
 
 
 
 V
 
 
 
8.1 TCR
transgenic lymph node lymphocytes were stimulated in vitro with
Mls-disparate splenocytes or with 
 
 
 
CD3 (145–2C11; BD Bio-
sciences). V
 
 
 
8.1 CD4
 
 
 
 lymphocytes (5 
 
 
 
 10
 
4
 
) and splenocytes (5 
 
 
 
10
 
5
 
 from CBA/J strain, prepared as described above) were cul-
tured together in 0.2 ml DMEM medium containing 100 IU/ml
penicillin and streptomycin, 1 mM 
 
l
 
-glutamine, 50 
 
 
 
M 2-mer-
captoethanol, and heat-inactivated 10% FBS in 96-well flat
bottomed plates at 37
 
 
 
C in a humidified environment containing
95%O
 
2
 
/5% CO
 
2
 
. Nontransgenic lymphocytes (C57Bl/6) were
stimulated in vitro with 1 
 
 
 
g/ml
 
  
 
CD3, 1 
 
 
 
g/ml 
 
 
 
CD28
(37.51; BD Biosciences), and APC’s to generate effector cells.
Anergic cells were generated in vitro by omitting 
 
 
 
CD28 Ab and
additionally treating with 10 
 
 
 
g/ml CTLA-4 Ig (provided by R.
Peach, Bristol-Myers Squibb Pharmaceuticals, Princeton, NJ),
again in the presence of APC’s. The use of CTLA-4 Ig markedly
reduces (
 
 
 
80%), but does not completely eliminate, proliferation
in this in vitro system (due to high strength of TCR signal).
However, we find that CTLA-4 Ig induces anergy, defined as a
failure to divide or make IL-2 upon restimulation in both the pri-
mary proliferating and nonproliferating cells (unpublished obser-
vations). The stimulus-dose dependence of proliferation was de-
termined with 
 
 
 
CD3 mAb (2C11; BD Biosciences) over a two
log concentration range ([
 
 
 
g/ml] 3, 1.0, 0.33, 0.11, and 0.037).
All proliferation experiments were performed in triplicate. DNA
synthesis was measured in vitro by labeling cells with 1.0 
 
 
 
Ci/
well [
 
3
 
H]thymidine (NEN Life Science Products) during the ter-
minal 6 h of culture and 48 h of stimulation with 
 
 
 
CD3 or 72 h
after stimulation with Mls-1
 
a
 
 in vitro.
To determine the proliferative history of T cells in vivo,
V
 
 
 
8.1 TCR
 
 
 
 transgenic lymph node lymphocytes were labeled
with the fluorescent dye 5-6-carboxyfluorescein diacetate succin-
imidyl ester (CFSE; Molecular Probes), which labels live cells and
segregates equally between daughter cells during mitosis, as de-
scribed previously (26). Lymphocytes labeled with CFSE were
injected into Mls-disparate mice (CBA/J) and harvested 2–4 d af-
ter inoculation to measure Kv currents and CFSE fluorescence
profiles of engrafted CD4
 
 
 
 cells. 
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Cytokine Measurements.
 
30 million beads (5-
 
 
 
m-diameter–
treated polystyrene; Interfacial Dynamics) were washed and sus-
pended in 0.5 ml PBS. The beads were next incubated with 2.5
 
 
 
g 
 
 
 
IL-2 or 
 
 
 
IFN-
 
 
 
 for 2–3 h at 37
 
 
 
C, washed once with com-
plete tissue culture medium, and suspended in 1 ml of culture
medium. Cytokine concentrations in culture supernatants were
calibrated using rIFN-
 
 
 
 and/or rIL-2 standards. The limit of de-
tection for the IFN-
 
 
 
 and IL-2 standard curves was 195 and 39
pg/ml, respectively. 50 
 
 
 
l of the supernatant to be tested was in-
cubated with 6 
 
 
 
l antibody-coated beads for 1 h at 37
 
 
 
C. The
beads were washed with PBS and then incubated with detection
antibody for 20 min at room temperature. The beads were
washed once and analyzed by flow cytometry.
IL-4 was measured in a standard sandwich ELISA. In brief, 5
 
 
 
g/ml 11B11 was added to Immulon 2 plates overnight at 4
 
 
 
C.
The plates were blocked for 45 min with PBS/10% FBS. 50 
 
 
 
l of
the supernatant was added for 1 h at 37
 
 
 
C. The plates were
washed with PBS/Tween 20 and biotinylated BVD-6 was added
at 1:1,000 for 1 h at 37
 
 
 
C. The plates were washed again and SA-
peroxidase was added for 30 min. Finally, the plates were washed,
ABTS (KPL) was added, and absorbance (510 nm) was detected
at 450 nm excitation.
 
Electrophysiological Recording.
 
Murine lymph node lympho-
cytes were stained with fluorescein- or phycoerythrin-conju-
gated monoclonal antibodies and placed in a recording chamber
mounted on an inverted fluorescent microscope (Nikon). Lym-
phocytes were stained with phycoerythrin-conjugated 
 
 
 
CD4
(RM4–5; BD Biosciences) and V
 
 
 
8.1 effector (day 3) lympho-
cytes were additionally incubated with unconjugated 3G11 (BD
Biosciences; references 27, 28) followed by FITC-conjugated
 
 
 
IgM (Jackson ImmunoResearch Laboratories). The phenotype
of each patched cell was determined before seal formation by
direct observation using a fluorescein/phycoerythrin dual filter
block (Chroma) and a 40
 
 
 
 oil immersion fluorescence objec-
tive (Nikon). Patch pipettes with a 4–6-M
 
 
 
 tip resistance were
pulled (Sutter Instrument Co.) from borosilicate glass and were
back-filled with solution containing 150 mg/ml nystatin
(Sigma-Aldrich). After formation of gigaohm seals (5–10 G
 
 
 
),
cells were lifted off the chamber bottom and held at 
 
 
 
70 mV.
Current measurements were initiated when the access resistance
decreased to 
 
 
 
50 M
 
 
 
 (
 
 
 
5–10 min after seal formation). Com-
mand potentials were generated and currents were acquired,
stored, and analyzed on a personal computer using an EPC-9
amplifier and PulseFit software (Heka). Data were sampled at 3
kHz and recorded on computer disk. For analysis, currents were
further filtered at 500 Hz. Unless stated otherwise, macroscopic
K
 
 
 
 currents were elicited with step depolarizations to 
 
 
 
50 mV
and currents were reported as peak whole cell currents. Current
densities were calculated by dividing the peak whole cell cur-
rent by the cell capacitance. Drugs were applied by direct addi-
tion to the bath. The bath solution contained the following
(mM): 155 NaCl, 4.5 KCl, 1 MgCl
 
2
 
, 2 CaCl
 
2
 
, 5 Na-HEPES,
and 5 glucose, pH 7.2. The pipette solution contained the fol-
lowing (mM): 155 KCl, 1 CaCl
 
2
 
, 1 MgCl
 
2
 
, and 10 K-Hepes,
pH 7.2. Recombinant CTX and MgTX were the gift of Maria
Garcia (Merck Laboratories, Rahway, NJ) and were also ob-
tained from Alomone Laboratories. Dendrotoxin-I (DTX-I)
and dendrotoxin-K (DTX-K) were obtained from Alomone
Laboratories.
 
Pharmacological Identification of Kv Current Components.
 
Kv
currents were defined pharmacologically using a variety of toxin
inhibitors including CTX (a blocker of Kv1.2, Kv1.3, Kv1.6, and
iKCa channels; references 29, 30), DTX-I (a blocker of Kv1.1,
 
Kv1.2, and Kv1.6 channels; reference 31), DTX-K (a blocker of
Kv1.1 channels; reference 32), and MgTX (a blocker of Kv1.1,
Kv1.2, Kv1.3, and Kv1.6 but not IK
 
Ca
 
) to define the identity of
K
 
 
 
 currents expressed by naive and primed CD4
 
 
 
 lymphocytes.
Because the only CTX-sensitive DTX-I–insensitive Kv channel
is Kv1.3, Kv1.3 was identified by first adding DTX-I, which
blocks Kv1.1, Kv1.2, or Kv1.6, and then CTX to block Kv1.3.
In some experiments, Kv1.1 currents were identified with DTX-
K, which is selective for Kv1.1. In these cases, any remaining
DTX-K–insensitive, DTX-I–sensitive Kv current is encoded by
Kv1.2 and/or Kv1.6. Because Kv1.2 and Kv1.6 are also sensitive
to CTX and specific blockers for either of these channels have
not been isolated, RT-PCR was used to determine whether
Kv1.2 or Kv1.6 mRNA is expressed in lymphocytes, as described
below.
 
Membrane Potential Measurements.
 
CD4
 
 
 
 lymphocytes were
identified as described above and membrane voltage was mea-
sured directly using the current clamp configuration of the nysta-
tin perforated patch-clamp technique. Whole cell Kv currents
were elicited after establishment of electrical access to the cyto-
plasm to confirm the cells differentiation state and viability. The
membrane potential was measured in cells that exhibited the ap-
propriate Kv current phenotype using the voltage clamp record-
ing mode. The role of Kv channels, defined in voltage-clamp ex-
periments, in setting the steady-state potential was determined by
sequentially blocking Kv1.1, Kv1.2, and Kv1.6 (with DTX-I),
Kv1.3 (with MgTX), and calcium-activated K (KCa) channels
(with CTX) as described above.
 
Intracellular Calcium Measurements.
 
Lymphocytes were loaded
with the cell permeant calcium indicator fura-2 AM (3.0 
 
 
 
M;
Molecular Probes) in RPMI medium for 15 min at room tem-
perature (25
 
 
 
C). During the final 10 min of fura-2 loading bio-
tinylated 
 
 
 
CD3 and  CD4 mAb were added to lymphocyte sus-
pensions. Cell suspensions were placed into the recording
chamber on an inverted fluorescent microscope (Nikon) and al-
lowed to adhere to 10  g/ml poly-l-lysine (Sigma-Aldrich)
treated coverslips for 5 min. Excess extracellular fura-2 AM and
unbound antibody was washed from the microscope recording
chamber with extracellular bath solution, which consisted of the
following (mM): 155 NaCl, 4.5 KCl, 2 CaCl2, 1 MgCl2, 5 glu-
cose, and 10 HEPES, pH 7.4. Discrete bandwidth excitation light
(340   10 nm, 380   10 nm) from a xenon source coupled to a
computer-controlled monochromator (TILL; Applied Scientific
Imaging) was delivered to the epifluorescence attachment of the
microscope through a quartz fiber optic guide. Excitation light
was directed through the fluorescent objective (100 ; Nikon)
via a dichroic mirror. The emitted fluorescence from fura-2–
loaded cells was passed through a 470-nm-long pass filter and im-
ages were obtained with an intensified charge-coupled video
camera (model C2400–68; Hammamatsu) connected to the side
port of the inverted microscope. Four fluorescent video images
were averaged and digitized (0.5 Hz) with a video frame grabber
(Matrox) using Metafluor acquisition and analysis software (Uni-
versal Imaging). Stored images were analyzed offline using the
Metafluor package. Within cursor-defined areas of interest paired
340/380 images were background subtracted and the ratio was
calculated. The absolute ratio values in the cursor-defined areas
were exported into Microsoft Excel and converted to [Ca2 ]
(33). Calibration factors, Rmax (340:380 ratio obtained in pres-
ence of 5  M ionomycin and 10 mM Ca2 ), Rmin (340:380 ratio
in presence of 5  M ionomycin and excess EGTA), and F380max
and F380min (minimum 510 nm emission with 380 nm excita-
tion) were determined in situ.900 Kv Channels and CD4  Lymphocyte Differentiation
RNA Preparation and RT-PCR. Total cellular RNA was pre-
pared according to the acid guanidinium method (34). Genomic
DNA was removed from RNA preparations by treating them
with DNase I (Boehringer) before cDNA synthesis with Super-
script II reverse transcriptase (Life Technologies). PCR was used
to amplify cDNA prepared from murine thymocyte RNA.
Unique complementary oligonucleotide primer pairs were syn-
thesized to unique 3  regions of Kv1.1 (sense, bases 979–1007,
ATCTTCAAACTCTCCCGCCACTCCAAGGG; antisense,
bases 1495–1476, TTGCTTTTTAAACATCGCT; Probe, bases
1292–1321, CTTAGCCTCTGACAGTGACC of the clone
MK1; reference 35), Kv1.2 (sense, as above; antisense bases
1667–1648 of cDNA clone RK2, ATATTCTGTGT-
TCTAAATCA; Probe, bases 1372–1391 of RK2, TACATG-
GAGATACAGGAGGG; (36), Kv1.3 (sense, as above; AS bases
1538–1521 of clone KV3, ACTTCAACTACTTCTAC-
CACCG; Probe, bases 1315–1336 of clone KV3, TTGGGGT-
TATTGTTCGTG (37), and Kv1.6 (sense, as above; antisense,
bases 1555–1536 of clone KV2, GATGTGGAGTTGGAAGG-
TAG; Probe, bases 1432–1451 of clone KV2, TATAC-
CCACGTCACTTGTGG (37). The specificity of each of these
oligonucleotide primer pairs was confirmed in test PCR reactions
using the appropriate mouse cDNA clone as a template (unpub-
lished data). PCR products were separated by electrophoresis in a
2% agarose gel and were capillary blotted onto Genescreen Plus
nylon membrane (NEN Dupont) in 0.4 M NaOH and 1.0 M
NaCl. DNA probes were 5 -end labeled with  -[32P]ATP using
T4 polynucleotide kinase according to the manufacturer’s proto-
col (Life Technologies).
Results
Voltage-dependent Potassium Currents Expressed by CD4 
Lymphocytes In Vivo. To determine whether Kv currents
are modulated by antigen stimulation of CD4  lympho-
cytes, we used an Mls-superantigen–specific V 8.1 TCR
transgenic mouse model to generate both anergized and
productively primed effector cells in vivo. In these mice,
superantigen induces a large proportion of CD4  lympho-
cytes to enter the cell cycle and proliferate, and the result-
ing expansion is evident as a large increase in CD4  cells
within 2–3 d. T cells isolated on day 3 contain productively
primed cells that are identified ex vivo according to their
expression levels of a disialoganglioside antigen termed
3G11 (Fig. 1 A). 3G11 expressed on naive T lymphocytes
is irreversibly down-modulated from the membrane of
productively primed effector T cells (27, 28). Importantly,
2 wk after the initiation of an immune response with su-
perantigen in V 8.1 TCR  mice, virtually all surviving
CD4  T cells, which express 3G11, are anergic by virtue of
a diminished capacity to produce IL-2 and proliferate (Fig.
1 B; reference 24).
Kv channels in naive and in vivo primed CD4  T cells
were maximally activated with a large step depolarization
(120 mV) from the holding potential ( 70 mV; Materials
and Methods) and currents were dissected with isoform-
selective Kv channel peptidyl blockers as described in Ma-
terials and Methods. Naive CD4  TCR transgenic cells ex-
press small amplitude Kv currents (peak amplitude  
51.0   4.3 pA, n   11; Fig. 2 A). Approximately 50% of
the evoked current of naive cells is blocked by 100 nM
CTX, whereas the remaining CTX-resistant current in naive
CD4  cells (21.4   4.7 pA, n   8) is sensitive to DTX-I
inhibition. Similar results are obtained regardless of the or-
der of blocker addition (unpublished data) and in either
case, neither toxin-defined current component exhibits sig-
nificant time-dependent inactivation. The fractional cur-
rent level after a 250-ms voltage step depolarization is
nearly identical to the initial peak current (0.95   0.02,
Figure 1. Functional characterization of CD4 
V 8.1 lymphocytes. FACS® analysis was performed to
determine the percentage of 3G11 expressing CD4 
cells on indicated days after inoculation. (A) The per-
centage of 3G11  lymph node lymphocytes decreases
during the first few days after Mls-1a superantigen in-
oculation and maximum steady-state number and per-
centage ( 50%) of 3G11  cells is observed on day 3
after antigen inoculation, after which the proportion of
CD4  3G11  cells progressively decreases. (B) CD4 
lymph node lymphocytes from control V 8.1 TCR
transgenic mice or from mice stimulated with Mls-
superantigen in vivo were restimulated with soluble
 CD3 mAb (145–2C11) and splenic APC’s in vitro.
Proliferation was assessed by measuring the amount of
[3H]thymidine (counts per minute) incorporation on
day 4 of culture for naive and cells previously primed
in vivo for 3 ( ) or 14 ( ) days. The proliferative ca-
pacity of day 14 lymphocytes was markedly de-
creased. Each value is the mean ( SD) of triplicate
cultures and the experiment shown is typical of three
similar experiments.901 Liu et al.
n   10). The amplitude and pharmacology of Kv currents
in CD4  lymphocytes from the background mouse strain
(CBACa) are quantitatively (30.0   1.3 pA, n   3) and
qualitatively similar (unpublished data).
As indicated above, antigen inoculation decreases 3G11
expression on  50% of CD4  lymphocytes in V 8.1
transgenic mice within 2–3 d (Fig. 1 A), which corre-
sponds to the time of peak proliferative expansion. Be-
cause not all cells proliferate in vivo, productively primed
cells were identified first by size. The membrane capaci-
tance, obtained with the patch clamp, was used to quan-
tify the cell surface area (volume) in productively primed/
proliferating cells, and 3G11  cells uniformly possess a
large membrane capacitance. In fact, the membrane ca-
pacitance of 3G11  CD4  cells is significantly larger than
3G11  CD4  cells isolated after antigen inoculation in
vivo (next section). In contrast to naive T cells, produc-
tively primed CD4  V 8.1 TCR transgenic lymphocytes
(day 3 3G11 ) generated in vivo express a larger (3–4
fold) amplitude Kv current (167.0   20.8 pA, n   15),
which exhibits prominent time (Fig. 2 B), use-, and volt-
age-dependent inactivation (unpublished data) at clamp
potentials positive to 0 mV. The fractional steady-state
current remaining after a 250-ms depolarization is  50%
of the peak current (0.43   0.07, n   11). Most signifi-
cantly, the entire Kv current of productively primed
CD4  lymphocytes is sensitive to CTX inhibition, and no
measurable CTX-resistant (DTX-K or DTX-I–sensitive)
current (see Fig. 5 B) is expressed.
Subsequent to the period of peak proliferative activity
( 3 d) in vivo, the absolute number and proportion of
productively primed (3G11 ) V 8.1 TCR Tg CD4  cells
decreases progressively and few can be found after 14 d of
stimulation in this model. Although a significant number
of CD4  (3G11 ) cells persist at 2 wk, these cells exhibit
an impaired ability to proliferate ex vivo (Fig. 1 B) on
stimulation with anti-CD3 mAb. This inability to prolif-
erate appears to result from a defect in the capacity to
produce IL-2 because these anergic cells will respond
to exogenous cytokine (38). Importantly, Kv currents
measured in anergic (day 14, 3G11 ) T cells are quantita-
tively and qualitatively distinct from those in naive and
productively primed cells. Compared with naive cells, the
peak current amplitude in anergic cells is larger (93.6  
13.3 pA, n   16) due to an increase in CTX-sensitive
(Kv1.3) current (96.0   19.6 pA, n   8, versus 44   6.9,
n   8 pA in naive cells), and anergic cell currents exhibit
some degree of time-dependent inactivation (Fig. 2 C).
The fractional current in anergized lymphocytes following
a 250 ms depolarization is 0.77   0.05 (n   16), which is
more than naive but less than productively primed effec-
tor cells. However, like naive cells anergic cells also ex-
press a DTX-I–sensitive (Kv1.1, Kv1.2, and/or Kv1.6)
current component.
Kv Current Density of Naive and Primed Lymphocytes.
Because lymphocytes enlarge as they progress through the
cell cycle, TCR-induced increases in whole cell Kv cur-
rent levels might simply reflect homeostatic regulation of
the plasma membrane channel density. To determine how
the increase in peak Kv current amplitude in Mls-superan-
tigen–stimulated lymphocytes relates to the increase in
surface area of stimulated cells, peak current values were
normalized to the membrane capacitance (Cm), which is
proportional to the cell surface area, to obtain a quantita-
tive measure of current (channel) density. The mean Cm
was 1.26   0.06 pF (n   12) for unstimulated, 1.86  
0.11 pF (n   20) for day 3 CD4  3G11 , and 1.69  
0.06 pF (n   15) for day 14 (anergized) CD4  (3G11 )
cells. Incidentally, the low capacitance (small volume) of
day 3 3G11  cells (1.37  0.15 pF, n   7) is consistent
with the premise that these are not productively primed.
Interestingly, naive (1.40   0.06 pF, n   16), day 3 (1.52  
0.06, n   12), and day 14 (1.44   0.07, n   14) CD8 
cells from V 8.1 TCR Tg mice exhibited no significant
capacitance differences.
Capacitance (surface area) normalized toxin-defined
current values (Kv current density) were found to be sig-
nificantly (P   0.05) higher in productively primed effec-
tor and anergic lymphocytes than in naive cells ( 2.3
times and 1.4-fold respectively; Fig. 3). The observed dif-
ferences in total current primarily reflects an increase in
CTX-sensitive current density (28.9   2.7 pA/pF, 112.4  
18.5 pA/pF, and 42.7   10.6 pA/pF for naive, effector,
and anergic cells, respectively). By contrast, the CTX-
resistant DTX-I–sensitive current density is essentially iden-
tical for resting and anergic CD4  lymphocytes (20.9  
Figure 2. Voltage-dependent potassium currents ex-
pressed by antigen specific lymphocytes in vivo. Kv cur-
rents were evoked with voltage step depolarizations from
 70 to  50 mV for 250 s in phenotypically defined
CD4  lymph node lymphocytes. Effector and anergic
lymphocytes were produced in vivo by inoculation of
V 8.1 Tg  mice with Mls-disparate splenocytes and re-
sponder cells isolated as described in Materials and Meth-
ods. Whole cell Kv current components were pharmaco-
logically defined with CTX (100 nM) or CTX (100 nM)  
DTX-I (100 nM) in naive/unprimed (A), productively
primed effector (B), and anergized (C) CD4  cells. The
latter two populations were isolated on days 3 and 14 af-
ter inoculation of V 8.1 TCR transgenic mice with Mls-
superantigen reactive B cells. Each series of recordings is
representative of at least eight separate experiments.902 Kv Channels and CD4  Lymphocyte Differentiation
4.3 pA/pF and 21.7   3.9 pA/pF, respectively). Impor-
tantly, the increase in Kv current density is about fourfold
greater (455   197 pA/pF, n   4) for CD4  V 8.1 TCR
transgenic lymphocytes that are inoculated into CBA/J
mice compared with those stimulated in V 8.1 TCR
transgenic mice by injection of superantigen. Conse-
quently, the larger Kv currents in productively primed and
anergic lymphocytes are not simply a function of increased
cell size or membrane surface area.
Regulation of Kv Currents by Strength of TCR Stimulation
and Costimulation. We next examined the regulation, by
TCR stimulation and CD28 costimulation, of Kv currents
in CD4  T cells. Naive nontransgenic cells (C57Bl/6
mice), like TCR transgenic cells, express a small amplitude
Kv current (peak amplitude   46.2   8.0 pA, n   6)
comprised of DTX-I–sensitive, and DTX-I–resistant, CTX-
sensitive components (Fig. 4 A). Because DTX-I inhibits
Kv1.1, Kv1.2, and Kv1.6, we examined the effects of the
Kv1.1-selective inhibitor DTX-K, which blocks a small
fraction of DTX-I–sensitive Kv current in naive cells
(22%, n   6; unpublished data). Effector cells were pro-
duced in vitro by stimulating naive cells with soluble
 CD3 and  CD28 antibodies in the presence of nonpuri-
fied splenocytes (APC’s) to provide costimulation and an-
tibody cross-linking. Effector cells produced in this way
exhibit relatively large amplitude Kv currents (374   48
pA, n   11), which are insensitive to DTX-I or DTX-K
(unpublished data), but are completely blocked by CTX
(Fig. 4 B) or MgTX (unpublished data). Finally, anergic
cells were generated by priming naive cells with  CD3
(no  CD28) and APCs, and by blocking B7-mediated co-
stimulatory signals with CTLA-4 Ig. Costimulatory block-
ade does not prevent the TCR-mediated increase in peak
Kv current levels compared with effector cells (peak cur-
rent   406.8   74.9 pA, n   11), but it does affect the
current composition. Anergized cells, unlike effector cells,
express a DTX-I–sensitive current component (Fig. 4 C).
A fraction (11%) of the DTX-I–sensitive Kv current of an-
ergized lymphocytes, like the similar current in naive cells,
is sensitive to DTX-K (45.6   13.1 pA, n   8). The re-
maining (DTX-K–resistant) current in anergic cells is
comprised of DTX-I (75   26 pA, n   5) and CTX-
(335   65 pA, n   3) sensitive components. Thus, the loss
of all DTX-sensitive current and an increase in CTX-sen-
sitive Kv current is associated with productive stimulation
of naive CD4  cells, whereas costimulatory blockade in
vitro results in an increase in CTX-sensitive Kv current,
and failure to down-modulate expression of DTX-sensi-
tive current components.
The consistently larger Kv current amplitude observed
in CD4  cells stimulated with  CD3 and  CD28 sug-
gested that Kv channel expression levels might be regu-
lated by the strength or “dose” of antigen. To address this
hypothesis, in vivo, V 8.1 TCR transgenic lymphocytes
were adoptively transferred into Mls-disparate (CBA/J)
mice in order to increase the stimulator/responder (CBA/
J:V 8.1 TCR Tg) cell ratio. By contrast with experiments
in which a limited number of stimulator cells are intro-
duced into V 8.1 transgenic mice, this approach intro-
duces V 8.1 responders into an environment (host) in
Figure 3. Kv current density in naive, effector, and anergic lympho-
cytes. Whole cell potassium currents were normalized to the cell surface
area (density) for multiple separate experiments (at least 10 measurements
for each condition) to determine whether the increase in Kv current is
proportional to the increased cell surface area in stimulated lymphocytes.
Effector and anergic lymphocytes were produced in vivo by inoculation
of V 8.1 TCR Tg mice with Mls-disparate splenocytes and T cells were
isolated as described in Materials and Methods. The current density of
proliferating (day 3, 3G11 ) lymphocytes (97   15 pA/pF) was  2.5-
fold greater than the aggregate current density of resting cells, that repre-
sents a 6–7-fold increase in CTX-sensitive current density. The CTX-
resistant current density for resting and day 14 lymphocytes is similar,
whereas the CTX-sensitive current density is about twofold greater in
day 14 than naive cells. The current in proliferating cells was significantly
larger than any other subpopulation. *, P   0.05.
Figure 4. Voltage-dependent potassium currents
expressed by CD4  V 8.1 TCR transgenic lympho-
cytes in vitro. Kv currents were evoked in voltage-
clamped CD4  lymph node lymphocytes with 250-
ms duration voltage step depolarizations from  70 to
 50 mV. The Kv current pharmacology was deter-
mined for CD4  lymphocytes with 100 nM DTX-I
or 100 nM DTX-I and 100 nM CTX in naive T
cells (A), or cells stimulated for 3 d in culture with 1
 g/ml  CD3 mAb and 1  g/ml  CD28, or 1  g/
ml  CD3 mAb and 10  g/ml CTLA-4 Ig in the
presence of APC’s to generate proliferating/effector (B) or anergic (C) populations of cells, respectively. CD4  lymphocytes were identified in
situ for patch-clamp measurements as described in Materials and Methods.903 Liu et al.
which nearly every cell expresses the reactive superanti-
gen. Before engraftment, transgenic lymphocytes were la-
beled with CFSE, so that their proliferative activity in vivo
could be assessed retrospectively. The CFSE profile of
CD4  cells isolated after adoptive transfer indicates that
most CD4  cells divide at least three times during the first
2 d of engraftment (Fig. 5 A). Surprisingly, the Kv current
(DTX I-insensitive, CTX-sensitive) of CFSE  CD4 
lymphocytes isolated 2 d after adoptive transfer is  25-
fold larger (741 pA   243 pA, n   4; Fig. 5 B) than cur-
rents in naive cells, and 4–5-fold larger than those in
CD4  cells activated with superantigen in V 8.1 TCR
transgenic mice (Fig. 2 B) or with anti-CD3 and anti-
CD28 in vitro (Fig. 4 B).
Molecular Identity of Kv Currents in Resting and Anergic
CD4   V 8.1 TCR Transgenic Lymphocytes. A limited
subset of all Kv channels (Kv1.1, Kv1.2, Kv1.3, and
Kv1.6) exhibit CTX and/or DTX sensitivity. Because
these toxins individually, or in combination with one an-
other, block all Kv currents in naive, effector, and anergic
CD4  cells (Figs. 2, 4, and 5 B), the currents must be en-
coded by one or more of these four genes. A pharmaco-
logical analysis of Kv currents was conducted to make as
many definitive identifications as possible. For example,
Kv1.3 is the only known DTX-I–resistant CTX-sensitive
Kv channel and Kv1.1 is the only known DTX-K–sensi-
tive channel. In contrast, Kv1.2 and Kv1.6 currents can-
not be distinguished from one another using available
blockers because both are sensitive to DTX-I and CTX
and neither is sensitive to DTX-K. Consequently, the
DTX-K–resistant DTX-I–sensitive Kv current in naive
and anergic CD4  cells could be encoded by either gene.
In fact, RT-PCR analysis revealed that mRNA for all
known CTX- and DTX-sensitive Kv channels (Kv1.1,
Kv1.2, Kv1.3, and Kv1.6) is expressed in murine CD4  T
cells (Fig. 6).
Coupling of Kv Channels to IL-2 Production in Naive CD4 
Lymphocytes. It is well established that a CTX-sensitive
Kv current (Kv1.3) underlies IL-2 production and prolif-
eration of naive human T cells (7, 9), although the func-
tions of Kv channels during secondary immune responses
in vivo or in vitro are unknown but likely to be distinct
(21, 22). We first tested the role of Kv channels during an-
tigen-mediated proliferative responses of naive CD4  T
cells in vitro to determine whether these murine models
recapitulate previous findings with human T cells. Naive
CD4  V  8.1 TCR lymphocytes were stimulated with
Mls-1a (irradiated CBA/J splenocytes) alone, as described
in Materials and Methods, and [3H]thymidine incorpora-
tion was used to measure the extent of DNA synthesis.
This superantigen stimulation protocol typically induces a
50-fold increase in [3H]thymidine incorporation into
DNA above the background response to control Mls non-
disparate (CBA/Ca and Mls-1b) cells. Importantly, both
CTX and DTX-I inhibit these in vitro responses (Fig. 7).
Although CTX reduced peak [3H]thymidine incorpora-
tion by 25%, CTX and DTX-I together exerted a greater
inhibitory effect ( 50%) than either blocker alone, indi-
cating that multiple Kv channel isoforms expressed by
CD4  lymphocytes regulate antigen-mediated responsive-
ness in vitro.
We next examined the mechanism by which blockers
might inhibit proliferation, and specifically tested the role
of each Kv current in the production of IL-2. Naive CD4 
Figure 5. Proliferative capacity and Kv currents of adoptively transferred
V 8.1  CD4  lymphocytes. CFSE labeled V 8.1 TCR transgenic lymph
node lymphocytes were inoculated into Mls-disparate (CBA/J) hosts and
were subsequently recovered (48 h after inoculation) to analyze the prolif-
erative history and Kv current phenotype of stimulated cells. (A) The
CFSE profile of inoculated CD4  lymphocytes, determined by flow cy-
tometry, demonstrates that the mean proliferative capacity of CD4  lym-
phocytes stimulated for 2 d in vivo was  10 (daughters) per responding T
lymphocyte and this reflects an average of three to four cell divisions. The
responder frequency was 73.6% in this experiment. (B) Patch-clamp mea-
surements of currents from the same population of CD4  CFSE  lympho-
cytes demonstrate a large amplitude Kv current, which is insensitive to
DTX-I (100 nM) but is completely blocked by CTX (100 nM).
Figure 6. Kv channel mRNA
expression in CD4  VB8.1
TCR transgenic lymphocytes.
RT-PCR was used to detect
mRNA that encodes CTX- and
DTX-I–sensitive potassium
channels (Kv1.1, Kv1.2, Kv1.3,
and Kv1.6; Materials and Meth-
ods) in CD4  V  8.1 TCR
transgenic lymphocytes. This autoradiograph demonstrates that Kv1.1,
Kv1.2, Kv1.3, and Kv1.6 mRNA are expressed in naive cells. Because Kv
channel genes are intronless (37, 48), we determined that these products
were not amplified from contaminating genomic DNA, which could be
present in the lymphocyte RNA preparations. In the absence of the re-
verse transcription step, PCR products of Kv1.1, Kv1.2, Kv1.3, or Kv1.6
were not amplified from lymphocyte mRNA preparations.904 Kv Channels and CD4  Lymphocyte Differentiation
lymphocytes, stimulated with plate immobilized anti-CD3,
were cultured in the absence or presence of CTX (to block
Kv1.3, Kv1.6, and KCa), DTX-I (to block Kv1.1 and
Kv1.6), DTX-K (to block Kv1.1 alone) and/or MgTX (to
block Kv1.1, Kv1.3, and Kv1.6 but not Ca2 -activated K
channels). Secreted cytokine was measured in culture su-
pernatants 16 h after initial activation. In the absence of Kv
channel blockers, stimulation led to the elaboration of a
significant amount of IL-2 (208 pg/ml, n   5), but produc-
tion was decreased by CTX (127 pg/ml, n   5) and DTX-I
(179 pg/ml, n   5) in CD3/CD28 primed naive CD4 
cells (39 and 14% inhibition, respectively; Fig. 8 A). The
effect of MgTX was similar to that of CTX, and the
Kv1.1-selective blocker DTX-K inhibited IL-2 production
to a similar extent as did DTX-I (unpublished data). How-
ever, the combination of CTX and DTX-I inhibited IL-2
production (104 pg, n   5) to a greater extent than did ei-
ther blocker alone. Predictably, costimulatory blockade
greatly decreased basal TCR-induced IL-2 levels ( 50%;
Fig. 8 B) and Kv channel inhibitors, except for the combi-
nation of CTX and DTX-I, induced little additional effect
on IL-2 production on restimulation in the presence of
CTLA-4 Ig.
Distinct Coupling of Kv Channels to Cytokine Production in
Effector versus Anergic CD4  T Cells. We also examined
whether Kv channels regulate cytokine production during
secondary responses of previously primed cells. CD4 
cells were first activated for 3 d in the presence of APCs
with either CD3 and CD28, or CD3 and CTLA-4 Ig,
and then rested for 24 h in fresh culture medium. IL-2,
IFN- , and IL-4 levels were each measured after restimu-
lation with plate-immobilized anti-CD3. None of the
blockers exerted a significant effect on IL-2, IFN- , or
IL-4 production by CD3/CD28 primed cells (Fig. 9 A),
nor IL-2 or IFN-  production during restimulation of
CTLA-4 Ig-treated T cells (Fig. 9 B). Unexpectedly, pro-
gressive inhibition of Kv channels in CTLA-4–treated
lymphocytes induced a significant and graded augmenta-
tion of IL-4 production that suggests Kv channels nor-
mally act to suppress IL-4 production by anergic T cells.
Thus, in addition to the well established requirement for
Kv channel activity during primary responses of T cells,
the repertoire of functions for Kv channels may also in-
clude a role in suppressing the transcription or elaboration
of cytokines.
Distinct Regulation of Membrane Potential by Kv Channels
in Naive, Effector, and Anergic CD4  Lymphocytes. Previ-
ously, we demonstrated that IL-2 production by naive
human T cells is modulated by changes in membrane
voltage (9). Given the differences in Kv channel activity
and the differential effects of Kv channel inhibitors on cy-
tokine production by naive, effector, and anergic murine
T cells, we directly measured Vm, and the contribution
of each defined Kv current to the steady-state Vm in each
of these T cell populations. The resting Vm was deter-
mined and then K  channel inhibitors were added to se-
lectively and sequentially inhibit different channel popu-
lations. DTX-I was applied first to block Kv1.1, Kv1.2,
and Kv1.6, and then MgTX was added to block Kv1.3
channels. MgTX was used because, unlike CTX, it does
not block calcium-activated potassium channels, which
may contribute to the membrane potential. After MgTX
addition, any effect of CTX would indicate that KCa
channels have an active role in setting Vm. Representa-
Figure 7. Potassium channel
blockers inhibit antigen-medi-
ated proliferation of CD4 
V 8.1 TCR transgenic lympho-
cytes. Mls-superantigen–stimu-
lated proliferative responses of
CD4  lymphocytes was assessed
in vitro by measuring [3H]thy-
midine incorporation into DNA
on day 4 of culture. Purified
V 8.1 TCR transgenic CD4 
lymphocytes were stimulated
with irradiated Mls-disparate
(CBA/J) splenocytes (stimulator/
responder ratio   10). Each bar
represents the mean ( SEM)
[3H]thymidine count from at least nine separate experiments. Each value
is expressed as a percentage of the control proliferative response obtained
in the absence or presence of CTX (100 nM) and/or DTX-I (100 nM)
for each individual trial. The mean [3H]thymidine incorporation for all
control experiments was 24,845   4,349 cpm (n   12). *, Mean value is
significantly different from control response (P   0.05). Non Mls-dispar-
ate stimulator cells (Mls-1b, CBACa) did not induce a proliferative re-
sponse in CD4  V 8.1 TCR transgenic lymphocytes. Figure 8. Effect of Kv channel blockers on IL-2 production by naive
CD4  lymphocytes in vitro. Naive CD4  lymphocytes from C57Bl/6
mice were stimulated (in the presence of APCs) with soluble  CD3 (1
 g/ml) and  CD28 (1  g/ml) in complete RPMI medium. Supernatants
were collected between 16 and 18 h after stimulation and assayed for
[IL-2] as described. Anergic cells were generated by omitting  CD28 and
including CTLA-4 Ig (10  g/ml) at the initiation of culture. Cells were
preincubated for at least 30 min with toxins before stimulation. All data
represent the mean of ( SD) of at least three separate experiments, each
performed in duplicate. When indicated, the results are significantly differ-
ent: *, P   0.05.905 Liu et al.
tive examples of recordings obtained from naive, effec-
tor, and anergic CD4  lymphocytes, generated in vitro
as described in Materials and Methods, are shown (Fig.
10). The results obtained from indicated numbers of in-
dividual cells and summarized in Table I demonstrate
that the Vm of naive cells is regulated by each pharma-
cologically defined Kv current we identified in voltage-
clamp experiments. DTX-I induces a small but consis-
tent depolarization and MgTX an additional decrease in
Vm to about  38 mV. The combination of DTX
and MgTX blocks all Kv channels expressed in mu-
rine CD4  T cells (demonstrated herein). Importantly,
DTX-I and MgTX had virtually no effect ( Vm   5
mV) on the Vm of effector cells generated in vivo or in
vitro (Fig. 10 and Table I). However, anergic cells, gen-
erated in vivo or in vitro, were sensitive to DTX-I.
Anergic T cells produced in vitro by blocking costimu-
lation were, however, somewhat different than cells an-
ergized in vivo, in that they exhibited sensitivity to both
DTX-I and MgTX. This difference may reflect the fact
that in vivo anergized cells also exhibit less prominent
time-dependent inactivation due to a more prominent
effect of DTX-I (nonactivating) Kv channels on their
phenotype.
Differential Regulation of Calcium Signaling by Kv Channels
in Naive, Effector, and Anergic T Cells. The different role of
Kv channels in regulating Vm of naive, effector, and anergic
lymphocytes would be expected to directly impact TCR-
mediated calcium influx because permeation of CRAC
channels is highly membrane potential dependent. We used
DTX-I and MgTX to determine whether membrane po-
tential and calcium signaling are coordinately regulated by
Kv channels in each distinct T cell population. Calcium was
mobilized by cross-linking CD3 and CD4 with biotinylated
mAb and streptavidin in the absence of blockers (Materials
and Methods) or in the presence of DTX-I and MgTX.
Stimulation of untreated cells induced an increase in [Ca2 ]i
in naive cells that quickly reached a peak concentration
(500–600 nM) and then decayed to an elevated steady-state
level ( 350 nM) over several minutes. DTX-I treatment
decreased the peak and plateau levels by  200 nM and
MgTX exerted an even greater inhibitory effect ( 100
nM). Anergic cells exhibited a similar blocker profile as na-
ive cells that is consistent with their effect on Vm. Signifi-
cantly, calcium signals in effector cells, like Vm (Fig. 10),
were not diminished by channel blockers, indicating that
neither the membrane potential nor calcium is regulated by
Kv channels in productively primed T lymphocytes.
Figure 9. Effect of Kv channel blockade on IL-2,
IL-4, and IFN-  production by effector and anergic
lymphocytes. Naive CD4  lymphocytes from C57Bl/6
mice were stimulated for 3 d in complete RPMI me-
dium with (A) soluble 1  g/ml  CD3 and 1  g/ml
 CD28 or (B) 1  g/ml  CD3 and 10  g/ml CTLA-4
Ig in the presence of APCs. Cells were collected,
washed, and recultured in complete medium in the ab-
sence of any stimuli for 24 h and restimulated with
plate-bound 1  g/ml   CD3. Culture supernatants
were collected between 16 and 18 h after restimulation
and assayed for IL-2, IL-4, and IFN-  as described.
Toxins were added to cells at least 30 min before stim-
ulation. All data represent the mean of ( SD) of at
least three separate experiments, each performed in du-
plicate. When indicated the results are significantly
different: *, P   0.05.
Figure 10. Regulation of membrane po-
tential by K  channels in naive, effector,
and anergic CD4  lymphocytes. The mem-
brane potential of naive, effector, and aner-
gic CD4  lymphocytes was recorded using
the current clamp mode of the patch-clamp
recording technique. Representative traces
are shown from naive CD4  lymphocytes,
and effector and anergic cells produced in
vitro from naive CD4  lymphocytes
(C57Bl/6) stimulated with  CD3 plus
 CD28 (B) or  CD3 and CTLA-4 Ig (C)
and APCs. The resting steady-state Vm was recorded in each cell type and toxins (100 nm) were sequentially added (as indicated) to the recording cham-
ber to determine the contribution of DTX-I–, MgTX-, and CTX-sensitive K  currents.906 Kv Channels and CD4  Lymphocyte Differentiation
Discussion
Voltage-gated potassium channels regulate physiological
and immunological functions of T lymphocytes including
adhesion molecule activation, the membrane potential,
calcium influx, effector cytokine production, clonal ex-
pansion, and cell death. Because naive lymphocytes are
multipotent, and their differentiation is modulated by dy-
namic interactions with antigen, costimulatory influences,
and microenvironmental factors, we asked whether func-
tional Kv channels (Kv currents), which are implicated in
these many T cell functions and fates, are coordinately or
dynamically regulated by the quality and quantity of prim-
ing in vitro and in vivo. In this paper, we have focused on
the modulation of functional Kv channels (currents) by
TCR and costimulatory signals, and the immunological
roles of these channels. We have identified qualitative and
quantitative changes in Kv currents that are linked to the
differentiation state of peripheral murine CD4  lympho-
cytes. Naive CD4  lymphocytes express a CTX-sensitive
current (Kv1.3) and a CTX-resistant DTX-I–sensitive
current. Part of this DTX-I–sensitive current of naive and
anergized T cells is also blocked by the Kv1.1 specific
blocker DTX-K. The remaining DTX-K–resistant DTX-
I–sensitive current is consistent with Kv1.2 and/or Kv1.6,
both of which are expressed at the mRNA level. Impor-
tantly, we find that the amplitude and composition of Kv
currents is regulated by the strength of TCR priming and
the presence or absence of costimulation. Strong/produc-
tive priming (in vitro or in vivo) suppresses all DTX-sensi-
tive Kv current and increases the amplitude of DTX-
resistant, CTX-sensitive (Kv1.3) current as previously
observed in mitogen-stimulated human and murine lym-
phocytes (18, 20). Incompletely primed/anergized CD4 
cells, like productively primed cells, express increased levels
of Kv1.3 current, but maintain relatively constant levels of
DTX-K–(Kv1.1) and DTX-I–sensitive current (Kv1.2/
Kv1.6).
Our in vivo and in vitro findings suggest that the quality
of TCR and costimulatory signals coordinately regulates
Kv channel expression/activity and CD4  lymphocyte dif-
ferentiation. Productive TCR/CD3-mediated signals seem
to be sufficient to induce an increase in Kv1.3 expression
because both effector and anergic cells express more Kv1.3
current than naive cells. However, costimulatory signals,
which appear to be mediated by CD28 stimulation, are re-
quired to initiate a decrease in DTX-sensitive Kv current,
and to prevent the induction of anergy. This tight corre-
spondence between Kv channel expression and CD4 
lymphocyte differentiation suggests that distinct Kv current
activities may support unique functions associated with
each immunological state. In fact, our data indicate that Kv
channels expressed by productively primed and anergized
lymphocytes differentially regulate secondary (TCR-depen-
dent) effector responses (cytokine production) of primed
lymphocytes (Fig. 9).
One important function of regulated K  efflux is the
production of an electronegative cell interior and a trans-
membrane electrical potential, which had been estimated
to be about  60 to  70 mV using indirect methods (6, 39,
40). This electrical gradient is necessary for stimulated cal-
cium influx, as the substantial inward concentration gradi-
ent is, remarkably, insufficient to drive   permeation
of activated CRAC channels in the absence of the K 
(channel) efflux-dependent membrane potential (8). Con-
sequently, the degree of membrane hyperpolarization (in-
tracellular negative charge) determines the magnitude of
the   influx via CRAC channels (8). Because Kv
channel inhibitors (DTX-I and/or MgTX) depolarize na-
ive and anergic T cells, it is not surprising that they also at-
tenuate TCR-mediated calcium signaling (Fig. 11). The
effect on Vm and calcium signaling, although incomplete,
is sufficient to affect cytokine production. In fact, we previ-
ously found significant inhibition of IL-2 production by
human T cells occurred in response to relatively small de-
polarizations (  25 mV; reference 9). Thus, the extent of
Kv blocker–mediated depolarization ( 30–50 mV) ob-
served in naive and anergic T cells also appears to be suffi-
cient to alter cytokine production by these populations.
Nonetheless, a significant proportion of the membrane po-
tential is not regulated by Kv channels, and calcium-acti-
vated K channels (41, 42) and electrogenic pathways such
as the Na /K  ATPase (sodium pump; reference 43) ex-
pressed in T cells are likely responsible for this residual Vm.
Cae
2 
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Table I. Effect of K  Blockers on the Membrane Potential of 
CD4  T Cells
Naive Effector Anergic
Nontransgenic CD4  cells generated in vitro
 66   8 mV  54   8 mV  72   1 mV
DTX-I  13   3 mVa  0.4   3 mV  16   5 mV
MgTX  28   5 mV  4   2 mV  16   4 mV
Vmb  26 mV  50 mV  40 mV
CTX  15   2 mV  29   6 mV  32   4 mV
Vmc  11 mV  21 mV  8 mV
n 557
V 8.1 TCR  CD4  cells generated in vivo
 65   3 mV  64   2 mV  66   3 mV
DTX-I  14   3 mV  0.8   0.5 mV  48   5 mV
MgTX  13   3 mV  4   2 mV   0   0 mV
Vmb  38 mV  59 mV  18 mV
CTX  21   3 mV  33   3 mV  3.5   4 mV
Vmc  17 mV  26 mV  14 mV
n 20 20 4
aMean change in membrane potential induced by each blocker is indi-
cated ( ). 
bCalculated membrane potential in the presence of DTX-1 and
MgTX.
cCalculated membrane potential in the presence of DTX-1, MgTX,
and CTX. 907 Liu et al.
A surprising result of these studies is the augmentation of
IL-4 production by Kv channel blockers in anergized
CD4  lymphocytes. This finding suggests that a more
complex repertoire of functions may exist for Kv channels
during other immunological responses of T cells. In aner-
gized cells, IL-4 augmentation by Kv channel inhibitors
may reflect the fact that low amplitude calcium signals bias
the cytokine profile toward the transcription/production of
IL-4 (and not IL-2) via the differential activation of
NFATc and NFATp (44). Thus, diminished calcium sig-
naling in partially primed (anergic) T cells may be analo-
gous to diminished (APL-like) calcium signaling, which has
been shown to induce IL-4 production upon restimulation
of incompletely primed cells.
Another unexpected finding was that Kv channels do
not regulate secondary physiological and immunological
responses of effector cells. Thus, although Kv1.3 expression
is increased, Kv channels neither contribute significantly to
the membrane potential, nor to calcium signaling and cyto-
kine production. This consistent pattern of insensitivity to
Kv blockers in effector cells provides an explanation for our
perplexing results, but also those of in vivo studies which
demonstrated that blockers suppressed primary responses to
antigen (Ab production and DTH responses) in miniswine,
and immune-mediated neurodegeneration during experi-
mentally-induced allergic encephalitis in the rat during pri-
mary antigen exposure, but not secondary responses to a
subsequent antigen challenge (21, 22).
The mere fact that Kv channels can uncouple from
membrane potential in effector cells is an interesting para-
dox because it has been shown that overexpression of
Kv1.3 channels (like that observed in effector cells) shifts
(hyperpolarizes) the membrane potential of a nonlymphoid
cell to that of naive T cells (45). In the context of our find-
ings with effector cells, this result demonstrates that in-
creased Kv1.3 expression alone is insufficient to establish
coupling to Vm, and that posttranslational mechanisms may
be involved or required. It is also possible that inherent dif-
ferences in the biophysical properties of individual channel
isoforms including the dominant effects of distinct subunits
in heterotetramers play a role in this regulation. In fact, the
Kv channel isoforms we have identified in T cells could
produce an array of oligomeric channel structures that de-
fine a wide flexibility or diversity of physiological activities
and immunological functions.
Although the oligomeric structure (subunit composi-
tion) of Kv channels cannot be determined with the patch
clamp, the changes in Kv channel expression level and
current kinetics we have observed in lymphocytes cer-
tainly reflect the aggregate phenotype of distinct popula-
tions of homooligomeric channels and/or the dominant
phenotype of heterooligomeric structures. In addition to
establishing a level of tonic activity, the oligomeric com-
position of lymphocyte Kv channels may also determine
their sensitivity to dynamic (posttranslational) modifica-
tions, such as phosphorylation, which regulate Kv channel
biophysical properties (46, 47). Thus, for example, IL-4
production and TH2 cell differentiation in vivo may be
specifically enhanced if Kv channel activity is suppressed
by intracellular signaling responses to external stimuli, by
physiological variations in the ionic composition or tonic-
ity of the external milieu at sites of activation or in-
flammation, or by TCR and CD28-regulated Kv channel
expression and/or oligomerization. These signaling path-
ways that dynamically regulate Kv channel activity or af-
fect their coupling to membrane potential and calcium
signaling in naive, effector, and anergic T cells represent
additional targets for Kv channel-mediated immune regu-
lation. Therefore, future studies will address the mecha-
nisms by which Kv currents are dynamically regulated in
naive and primed cells and the consequences for immune
function.
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Figure 11. Regulation of cal-
cium signaling by Kv channels
in naive, effector and anergic
CD4  lymphocytes. The intra-
cellular calcium concentration
was measured in naive (A), effec-
tor (B), and anergic (C) CD4 
lymphocytes, which were gen-
erated in vitro as described in
Materials and Methods. Each
trace represents the average cal-
cium concentration in at least 50
CD4  cells and calcium signals
were initiated by cross-linking
receptor bound biotin-conju-
gated  CD3 and  CD4 mAb with 1  g/ml streptavidin. The effect of 100 nM DTX-I and 100 nM MgTX were determined in consecutive experi-
ments on the same cell preparations and results shown are typical of three separate cell preparations for each population.908 Kv Channels and CD4  Lymphocyte Differentiation
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